$ALMU

Aeluma, Inc.

CIK:0001828805|SEC Filings

Consolidated Statements of Operations - USD ($) $ in Thousands	12 Months Ended
	Jun. 30, 2026	Jun. 30, 2025
Income Statement [Abstract]
Revenue	$ 4,461	$ 4,665
Operating expenses:
Cost of revenue	2,889	1,884
Research and development	4,668	1,295
General and administrative	7,090	3,628
Total operating expenses	14,647	6,807
Loss from operations	(10,186)	(2,142)
Other income (expense):
Interest income	1,027	113
Amortization of discount on convertible notes		(715)
Changes in fair value of derivative liabilities		(278)
Total other income (expense), net	1,027	(880)
Loss before income tax expense	(9,159)	(3,022)
Income tax expense
Net loss	$ (9,159)	$ (3,022)
Net loss per share - Basic (in Dollars per share)	$ (0.52)	$ (0.23)
Net loss per share - Diluted (in Dollars per share)	$ (0.52)	$ (0.23)
Weighted average common shares outstanding - Basic (in Shares)	17,665,755	13,168,345
Weighted average common shares outstanding - Diluted (in Shares)	17,665,755	13,168,345

Consolidated Statements of Cash Flows - USD ($) $ in Thousands	12 Months Ended
	Jun. 30, 2026	Jun. 30, 2025
Operating activities:
Net loss	$ (9,159)	$ (3,022)
Adjustments to reconcile net loss to net cash used in operating activities:
Amortization of deferred compensation		20
Stock-based compensation expense	4,519	1,893
Depreciation and amortization expense	451	415
Amortization of discount on convertible notes		715
Changes in fair value of derivative liabilities		278
Changes in operating assets and liabilities:
Accounts receivable	622	(902)
Prepaids and other current assets	(332)	(611)
Other assets	(7)
Accounts payable	(20)	44
Accrued expenses and other current liabilities	660	22
Net cash used in operating activities	(3,266)	(1,148)
Investing activities:
Purchase of equipment	(646)	(161)
Net cash used in investing activities	(646)	(161)
Financing activities:
Proceeds from stock option exercise	104	25
Proceeds from stock warrant exercise	708
Proceeds from convertible notes issuance		3,145
Proceeds from public offerings, net of offering costs	43,478	12,588
Payment for taxes related to net share settlement of stock options and restricted stock units	(112)
Net cash provided by financing activities	44,178	15,758
Net change in cash and cash equivalents, and certificate of deposit	40,266	14,449
Cash and cash equivalents, and certificate of deposit, beginning of period	15,740	1,291
Cash and cash equivalents, and certificate of deposit, end of period	56,006	15,740
Supplemental non-cash disclosures:
Right of use asset - operating obtained in exchange for lease liability -operating	1,014
Conversion of convertible notes to stockholders’ equity		1,667
Conversion of derivative liabilities to stockholders’ equity		$ 2,471

Consolidated Balance Sheets - USD ($) $ in Thousands	Jun. 30, 2026	Jun. 30, 2025
Current assets:
Cash and cash equivalents	$ 56,006	$ 3,628
Certificate of deposit		12,112
Accounts receivable	340	962
Prepaids and other current assets	965	633
Total current assets	57,311	17,335
Property and equipment:
Equipment	2,338	1,692
Leasehold improvements	547	547
Accumulated depreciation	(1,469)	(1,021)
Property and equipment, net	1,416	1,218
Right of use asset - operating	1,916	836
Other assets	21	17
Total assets	60,664	19,406
Current liabilities:
Accounts payable	341	361
Accrued expenses and other current liabilities	1,369	206
Lease liability – operating, current portion	180	138
Total current liabilities	1,890	705
Lease liability - operating, long-term portion	1,842	803
Total liabilities	3,732	1,508
Commitments and contingencies
Stockholders’ equity:
Preferred stock, $0.0001 par value: 10,000,000 authorized, and none issued and outstanding at June 30, 2026 and 2025
Common stock, $0.0001 par value: 50,000,000 shares authorized, and 19,257,755 and 15,864,360 shares issued and outstanding at June 30, 2026 and 2025, respectively	2	2
Additional paid-in capital	82,735	34,542
Accumulated deficit	(25,805)	(16,646)
Total stockholders’ equity	56,932	17,898
Total liabilities and stockholders’ equity	$ 60,664	$ 19,406